BIO-TECHNE Corp (TECH)

Biological Products, (No Diagnostic Substances)

Latest Price

$72.27

TTM P/E

104.52

Normalized P/E

32.02

Div Yield

0.44%

Book Value

13.38

P/B Ratio

5.40

Valuation metrics

EPS: $1.16

Book value / share: $13.51

Formula: √(22.5 × EPS × BVPS)

Graham Number

$18.78

74% downside

Norm. op. income: $237M (median of 7yr)

Tax rate: 16%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$13.23

82% downside

Base FCF: $257M (median of recent 5yr)

Growth: 6%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$29.79

59% downside

EPS: $1.16

Target P/E: 32×

Formula: EPS × P/E

P/E Fair Value

$37.12

49% downside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	14.03M	$990.0M	8.99%	+1.76M	2026-06-30
FMR LLC	12.79M	$903.0M	8.20%	+4.89M	2026-06-30
VANGUARD CAPITAL MANAGEMENT LLC	10.22M	$721.0M	6.55%	+38.8K	2026-06-30
GOLDMAN SACHS GROUP INC	7.34M	$518.0M	4.70%	+5.40M	2026-06-30
HBK INVESTMENTS L P	6.83M	$482.0M	4.37%	--	2026-06-30
VANGUARD PORTFOLIO MANAGEMENT LLC	6.51M	$459.0M	4.17%	+26.0K	2026-06-30
MORGAN STANLEY	6.37M	$450.0M	4.08%	-2.16M	2026-06-30
STATE STREET CORP	5.98M	$422.0M	3.83%	+112.0K	2026-06-30
GEODE CAPITAL MANAGEMENT, LLC	5.35M	$377.0M	3.43%	+239.0K	2026-06-30
Invesco Ltd.	4.99M	$352.0M	3.19%	+397.7K	2026-06-30